Flagship Ventures General Partner LLC insider trades: BIND Therapeutics (BIND) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Flagship Ventures General Partner LLC reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 25, 2013 | BIND | ↑ Buy | 20,000 | $15.00 | $300K | Indirect | Sep 27, 2013 (2d) |
| Mar 25, 2013 | TTPH | ↑ Buy | 491,824 | $7.00 | $3.4M | Direct | Mar 27, 2013 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Flagship Ventures General Partner LLC's insider trades
Flagship Ventures General Partner LLC is a 10% owner of BIND Therapeutics (BIND). Since Mar 25, 2013, it has reported 2 open-market purchases worth $3.7M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (5 filings), grants and awards (3 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BIND insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.